Jayaram H, Kolko M, Friedman DS, Gazzard G (2023) Glaucoma: now and beyond. Lancet 402(10414):1788–1801

Article  PubMed  Google Scholar 

Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311(18):1901–1911

Article  PubMed  PubMed Central  Google Scholar 

Mohan N, Chakrabarti A, Nazm N, Mehta R, Edward DP (2022) Newer advances in medical management of glaucoma. Indian J Ophthalmol 70(6):1920–1930

Article  PubMed  PubMed Central  Google Scholar 

Salvetat ML, Pellegrini F, Spadea L, Salati C, Zeppieri M (2023) Pharmaceutical approaches to normal tension glaucoma. Pharmaceuticals (Basel) 16(8):1172

Article  PubMed  Google Scholar 

Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM (2021) Inflammation in glaucoma: from the back to the front of the eye, and beyond. Prog Retin Eye Res 83:100916

Article  PubMed  Google Scholar 

Mélik Parsadaniantz S, Réaux-le Goazigo A, Sapienza A, Habas C, Baudouin C (2020) Glaucoma: a degenerative optic neuropathy related to neuroinflammation? Cells 9(3):535

Article  PubMed  PubMed Central  Google Scholar 

Jassim AH, Inman DM, Mitchell CH (2021) Crosstalk between dysfunctional mitochondria and inflammation in glaucomatous neurodegeneration. Front Pharmacol 12:699623

Article  PubMed  PubMed Central  Google Scholar 

Sapienza A, Raveu AL, Reboussin E, Roubeix C, Boucher C, Dégardin J et al (2016) Bilateral neuroinflammatory processes in visual pathways induced by unilateral ocular hypertension in the rat. J Neuroinflamm 13:44

Article  Google Scholar 

Adornetto A, Russo R, Parisi V (2019) Neuroinflammation as a target for glaucoma therapy. Neural Regen Res mars 14(3):391–394

Article  Google Scholar 

Wei X, Cho KS, Thee EF, Jager MJ, Chen DF (2019) Neuroinflammation and microglia in glaucoma: time for a paradigm shift. J Neurosci Res 97(1):70–76

Article  PubMed  Google Scholar 

Quaranta L, Bruttini C, Micheletti E, Konstas AGP, Michelessi M, Oddone F et al (2021) Glaucoma and neuroinflammation: an overview. Surv Ophthalmol 66(5):693–713

Article  PubMed  Google Scholar 

Tezel G (2022) Molecular regulation of neuroinflammation in glaucoma: current knowledge and the ongoing search for new treatment targets. Prog Retin Eye Res 87:100998

Article  PubMed  Google Scholar 

Ramirez AI, de Hoz R, Salobrar-Garcia E, Salazar JJ, Rojas B, Ajoy D et al (2017) The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma. Front Aging Neurosci 9:214

Article  PubMed  PubMed Central  Google Scholar 

Miao Y, Zhao GL, Cheng S, Wang Z, Yang XL (2023) Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma. Prog Retin Eye Res 93:101169

Article  PubMed  Google Scholar 

Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53(2):1181–1194

Article  PubMed  Google Scholar 

Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B et al (2022) Microglia states and nomenclature: a field at its crossroads. Neuron 110(21):3458–3483

Article  PubMed  PubMed Central  Google Scholar 

Wang SK, Cepko CL (2022) Targeting microglia to treat degenerative eye diseases. Front Immunol 13:843558

Article  PubMed  PubMed Central  Google Scholar 

Wang JW, Chen SD, Zhang XL, Jonas JB (2016) Retinal microglia in glaucoma. J Glaucoma 25(5):459–465

Article  PubMed  Google Scholar 

Berrino E, Supuran CT (2019) Rho-kinase inhibitors in the management of glaucoma. Expert Opin Ther Pat 29(10):817–827

Article  PubMed  Google Scholar 

Saha BC, Kumari R, Kushumesh R, Ambasta A, Sinha BP (2022) Status of Rho kinase inhibitors in glaucoma therapeutics-an overview. Int Ophthalmol 42(1):281–294

Article  PubMed  Google Scholar 

Al-Humimat G, Marashdeh I, Daradkeh D, Kooner K (2021) Investigational Rho kinase inhibitors for the treatment of glaucoma. J Exp Pharmacol 13:197–212

Article  PubMed  PubMed Central  Google Scholar 

Schehlein EM, Robin AL (2019) Rho-associated kinase inhibitors: evolving strategies in glaucoma treatment. Drugs 79(10):1031–1036

Article  PubMed  Google Scholar 

Koch JC, Tatenhorst L, Roser AE, Saal KA, Tönges L, Lingor P (2018) ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacol Ther 189:1–21

Article  PubMed  Google Scholar 

Chong CM, Ai N, Lee SMY (2017) ROCK in CNS: different roles of isoforms and therapeutic target for neurodegenerative disorders. Curr Drug Targets 18(4):455–462

Article  PubMed  Google Scholar 

Aguilar BJ, Zhu Y, Lu Q (2017) Rho GTPases as therapeutic targets in Alzheimer’s disease. Alzheimers Res Ther 9(1):97

Article  PubMed  PubMed Central  Google Scholar 

Van de Velde S, De Groef L, Stalmans I, Moons L, Van Hove I (2015) Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics. Prog Neurobiol 131:105–119

Article  PubMed  Google Scholar 

Raad M, El Tal T, Gul R, Mondello S, Zhang Z, Boustany RM et al (2012) Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma. Electrophoresis 33(24):3659–3668

Article  PubMed  Google Scholar 

Alt A, Hilgers RD, Tura A, Nassar K, Schneider T, Hueber A et al (2013) The neuroprotective potential of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in response to hypoxia in isolated bovine retina. Cell Physiol Biochem 32(1):218–234

Article  PubMed  Google Scholar 

Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU, Henke-Fahle S (2009) Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Invest Ophthalmol Vis Sci 50(1):452–461

Article  PubMed  Google Scholar 

Sato K, Ohno-Oishi M, Yoshida M, Sato T, Aizawa T, Sasaki Y et al (2023) The GPR84 molecule is a mediator of a subpopulation of retinal microglia that promote TNF/IL-1α expression via the rho-ROCK pathway after optic nerve injury. Glia 71(11):2609–2622

Article  PubMed  Google Scholar 

Holan V, Palacka K, Hermankova B (2021) Mesenchymal stem cell-based therapy for retinal degenerative diseases: experimental models and clinical trials. Cells 10(3):588

Article  PubMed  PubMed Central  Google Scholar 

Reboussin É, Buffault J, Brignole-Baudouin F, Réaux-Le Goazigo A, Riancho L, Olmiere C et al (2022) Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model. J Neuroinflamm 19(1):63

Article  Google Scholar 

Li Y, Zhang Y, Qi S, Su G (2018) Retinal organotypic culture—a candidate for research on retinas. Tissue Cell 51:1–7

Article  PubMed  Google Scholar 

Schnichels S, Paquet-Durand F, Löscher M, Tsai T, Hurst J, Joachim SC et al (2021) Retina in a dish: cell cultures, retinal explants and animal models for common diseases of the retina. Prog Retin Eye Res 81:100880

Article  PubMed  Google Scholar 

Rettinger CL, Wang HC (2018) Current advancements in the development and characterization of full-thickness adult neuroretina organotypic culture systems. Cells Tissues Organs 206(3):119–132

Article